Fonte: Circulation. Unidade: FMRP
Assuntos: INSUFICIÊNCIA RENAL AGUDA, ANGIOCARDIOGRAFIA, ANGIOPLASTIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BERWANGER, Otavio e MARIN NETO , José Antonio. Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized acetylcysteine for contrast-induced nephropathy trial (ACT). Circulation, v. 124, n. 11, p. 1250-1259, 2011Tradução . . Disponível em: https://doi.org/10.1161/CIRCULATIONAHA.111.038943. Acesso em: 01 nov. 2024.APA
Berwanger, O., & Marin Neto , J. A. (2011). Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized acetylcysteine for contrast-induced nephropathy trial (ACT). Circulation, 124( 11), 1250-1259. doi:10.1161/CIRCULATIONAHA.111.038943NLM
Berwanger O, Marin Neto JA. Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized acetylcysteine for contrast-induced nephropathy trial (ACT) [Internet]. Circulation. 2011 ; 124( 11): 1250-1259.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1161/CIRCULATIONAHA.111.038943Vancouver
Berwanger O, Marin Neto JA. Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized acetylcysteine for contrast-induced nephropathy trial (ACT) [Internet]. Circulation. 2011 ; 124( 11): 1250-1259.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1161/CIRCULATIONAHA.111.038943
